Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
Essent continues to broaden its highly characterized, low passage primary cell catalog
An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines
WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility
The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021
The plant is scheduled to come on stream in September 2024
Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Subscribe To Our Newsletter & Stay Updated
